As the pharmaceutical industry pushes towards full DSCSA compliance this November, stakeholders and the FDA have made efforts to streamline and improve processes to ensure the security and integrity of the drug supply chain.
This year’s Asembia Summit was not just an event; it was a powerhouse of innovation and strategic conversations that set new benchmarks for patient care within the pharmaceutical industry. Asembia served as the nexus for fostering connections and driving transformative ideas. Below, we dive into the key insights and takeaways that are steering our industry toward a more innovative and efficient future, spotlighting the groundbreaking work and collaborations that are defining the path forward.
The medical device industry is growing, and we’re seeing the impact at Two Labs as more and more clients are asking us for support in launching their new medical device products.
